In the era of targeted therapy, many have argued that targeted therapies would not only be more effective but also less toxic. However, the early evidence suggests that the assumption that greater specificity would result in greater efficacy may have been premature. In fact, it can be argued that dirty may be better than clean.
No takes yet. Share an insight, caveat, or question.
Tito Fojo (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: